Control of Intestinal Epithelial Permeability by Lysophosphatidic Acid Receptor 5

Autor: Mo Wang, C. Chris Yun, Yiran Han, Lei Dong, Peijian He
Jazyk: angličtina
Rok vydání: 2021
Předmět:
0301 basic medicine
Male
Lipopolysaccharide
RC799-869
RT-PCR
reverse transcriptase polymerase chain reaction

IEC
intestinal epithelial cell

Cell membrane
chemistry.chemical_compound
Transactivation
Mice
0302 clinical medicine
LPA5
FD-4
fluorescein isothiocyanate-labeled 4 kDa dextran

Lysophosphatidic acid
Intestinal Mucosa
Receptors
Lysophosphatidic Acid

Receptor
Original Research
ATX
autotaxin

IBD
inflammatory bowel disease

Dextran Sulfate
Gastroenterology
Diseases of the digestive system. Gastroenterology
GI
gastrointestinal

Colitis
Cell biology
LPA
medicine.anatomical_structure
TJ
tight junction

shRNA
short hairpin RNA

LPS
lipopolysaccharide

030211 gastroenterology & hepatology
Signal transduction
JAMs
junctional adhesion molecules

Rac1
LPA
lysophosphatidic acid

LPA5
LPA receptor 5

Barrier
PBS
phosphate-buffered saline

RAC1
ROCK
RhoA-associated kinase

Permeability
TER
transepithelial electrical resistance

Cell Line
GEF
guanine nucleotide exchange factor

03 medical and health sciences
Stat
signal transducers and activators of transcription

DSS
dextran sulfate sodium

medicine
Animals
Humans
IF
immunofluorescence

GPCR
G protein-coupled receptor

Intestinal permeability
Hepatology
Stat3
NHE3
Na+/H+ exchanger 3

medicine.disease
AJ
adherens junction

EGFR
epidermal growth factor receptor

Disease Models
Animal

030104 developmental biology
chemistry
Caco-2 Cells
Lysophospholipids
SD
standard deviation
Zdroj: Cellular and Molecular Gastroenterology and Hepatology
Cellular and Molecular Gastroenterology and Hepatology, Vol 12, Iss 3, Pp 1073-1092 (2021)
ISSN: 2352-345X
Popis: Background & Aims Epithelial cells form a monolayer at mucosal surface that functions as a highly selective barrier. Lysophosphatidic acid (LPA) is a bioactive lipid that elicits a broad range of biological effects via cognate G protein-coupled receptors. LPA receptor 5 (LPA5) is highly expressed in intestinal epithelial cells, but its role in the intestine is not well-known. Here we determined the role of LPA5 in regulation of intestinal epithelial barrier. Methods Epithelial barrier integrity was determined in mice with intestinal epithelial cell (IEC)-specific LPA5 deletion, Lpar5ΔIEC. LPA was orally administered to mice, and intestinal permeability was measured. Dextran sulfate sodium (DSS) was used to induce colitis. Human colonic epithelial cell lines were used to determine the LPA5-mediated signaling pathways that regulate epithelial barrier. Results We observed increased epithelial permeability in Lpar5ΔIEC mice with reduced claudin-4 expression. Oral administration of LPA decreased intestinal permeability in wild-type mice, but the effect was greatly mitigated in Lpar5ΔIEC mice. Serum lipopolysaccharide level and bacterial loads in the intestine and liver were elevated in Lpar5ΔIEC mice. Lpar5ΔIEC mice developed more severe colitis induced with DSS. LPA5 transcriptionally regulated claudin-4, and this regulation was dependent on transactivation of the epidermal growth factor receptor, which induced localization of Rac1 at the cell membrane. LPA induced the translocation of Stat3 to the cell membrane and promoted the interaction between Rac1 and Stat3. Inhibition of Stat3 ablated LPA-mediated regulation of claudin-4. Conclusions This study identifies LPA5 as a regulator of the intestinal barrier. LPA5 promotes claudin-4 expression in IECs through activation of Rac1 and Stat3.
Graphical abstract
Databáze: OpenAIRE